ATE419536T1 - Biospezifische kontrastmittel - Google Patents
Biospezifische kontrastmittelInfo
- Publication number
- ATE419536T1 ATE419536T1 AT03711417T AT03711417T ATE419536T1 AT E419536 T1 ATE419536 T1 AT E419536T1 AT 03711417 T AT03711417 T AT 03711417T AT 03711417 T AT03711417 T AT 03711417T AT E419536 T1 ATE419536 T1 AT E419536T1
- Authority
- AT
- Austria
- Prior art keywords
- sample
- condition
- quantum dots
- metallic nanoparticles
- contrast agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0058—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36192402P | 2002-03-05 | 2002-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE419536T1 true ATE419536T1 (de) | 2009-01-15 |
Family
ID=27805093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03711417T ATE419536T1 (de) | 2002-03-05 | 2003-03-05 | Biospezifische kontrastmittel |
Country Status (7)
Country | Link |
---|---|
US (2) | US20040023415A1 (de) |
EP (1) | EP1487343B1 (de) |
AT (1) | ATE419536T1 (de) |
AU (1) | AU2003213729A1 (de) |
CA (1) | CA2478083A1 (de) |
DE (1) | DE60325564D1 (de) |
WO (1) | WO2003075765A1 (de) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8614169B2 (en) * | 2001-12-04 | 2013-12-24 | Wayne State University | Neoepitope detection of disease using protein arrays |
US7964536B2 (en) * | 2001-12-04 | 2011-06-21 | Wayne State University | Neoepitope detection of disease using protein arrays |
ATE419536T1 (de) * | 2002-03-05 | 2009-01-15 | Univ Texas | Biospezifische kontrastmittel |
IL165033A0 (en) | 2002-05-07 | 2005-12-18 | Univ California | Bioactivation of particles |
US7810380B2 (en) | 2003-03-25 | 2010-10-12 | Tearlab Research, Inc. | Systems and methods for collecting tear film and measuring tear film osmolarity |
US8020433B2 (en) * | 2003-03-25 | 2011-09-20 | Tearlab Research, Inc. | Systems and methods for a sample fluid collection device |
US6965434B2 (en) * | 2002-09-13 | 2005-11-15 | Centre National De La Recherche Scientifiques (C.N.R.S.) | Method and device for photothermal imaging tiny metal particles immersed in a given medium |
US7623908B2 (en) * | 2003-01-24 | 2009-11-24 | The Board Of Trustees Of The University Of Illinois | Nonlinear interferometric vibrational imaging |
JP4787938B2 (ja) * | 2003-03-28 | 2011-10-05 | ザ・プロウボウスト・フェロウズ・ファウンデーション・スカラーズ・アンド・ザ・アザー・メンバーズ・オブ・ボード・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン | 銀ナノ粒子を用いた検体検出用センサ |
US20050250094A1 (en) * | 2003-05-30 | 2005-11-10 | Nanosphere, Inc. | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes |
WO2005040755A2 (en) * | 2003-10-20 | 2005-05-06 | The Regents Of The University Of California | Nanoscale transduction systems for detecting molecular interactions |
US7790473B2 (en) * | 2003-11-05 | 2010-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Biofunctionalized quantum dots for biological imaging |
US7610074B2 (en) * | 2004-01-08 | 2009-10-27 | The Board Of Trustees Of The University Of Illinois | Multi-functional plasmon-resonant contrast agents for optical coherence tomography |
DE102004013052A1 (de) * | 2004-03-10 | 2005-09-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Charakterisierung von technischen Oberflächen |
US20050220714A1 (en) * | 2004-04-01 | 2005-10-06 | Susan Kauzlarich | Agents for use in magnetic resonance and optical imaging |
US8128908B2 (en) * | 2004-04-30 | 2012-03-06 | University Of Florida Research Foundation, Inc. | Nanoparticles and their use for multifunctional bioimaging |
WO2006093516A2 (en) | 2004-06-22 | 2006-09-08 | The Regents Of The University Of California | Peptide-coated nanoparticles with graded shell compositions |
US7655479B2 (en) * | 2004-06-30 | 2010-02-02 | University Of South Florida | Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection |
US20060057627A1 (en) * | 2004-09-08 | 2006-03-16 | Board Of Regents, The University Of Texas System | Selection scheme for enzymatic function |
CA2520670A1 (en) * | 2004-09-23 | 2006-03-23 | National Research Council Of Canada | Nanocrystal coated surfaces |
US20080093550A1 (en) * | 2004-11-12 | 2008-04-24 | Seoul National University Industry Foundation | Method For Adhering Nanostructures to End of Probe of Microscope and Microscope Having Probe Made By the Same Method |
US7307774B1 (en) | 2005-01-24 | 2007-12-11 | The Board Of Trustees Of The Leland Standford Junior University | Micro-optical analysis system and approach therefor |
US8346346B1 (en) | 2005-01-24 | 2013-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Optical analysis system and approach therefor |
US8788021B1 (en) | 2005-01-24 | 2014-07-22 | The Board Of Trustees Of The Leland Stanford Junior Univerity | Live being optical analysis system and approach |
US7586618B2 (en) | 2005-02-28 | 2009-09-08 | The Board Of Trustees Of The University Of Illinois | Distinguishing non-resonant four-wave-mixing noise in coherent stokes and anti-stokes Raman scattering |
US7725169B2 (en) * | 2005-04-15 | 2010-05-25 | The Board Of Trustees Of The University Of Illinois | Contrast enhanced spectroscopic optical coherence tomography |
US7801590B2 (en) * | 2005-05-27 | 2010-09-21 | Board Of Regents, The University Of Texas System | Optical coherence tomographic detection of cells and killing of the same |
US8355776B2 (en) | 2005-05-27 | 2013-01-15 | Board Of Regents, The University Of Texas System | Hemoglobin contrast in magneto-motive optical doppler tomography, optical coherence tomography, and ultrasound imaging methods and apparatus |
CN101951982A (zh) * | 2005-05-27 | 2011-01-19 | 德克萨斯大学体系董事会 | 细胞和组合物的光学相干断层扫描术检测 |
EP1894003A2 (de) | 2005-06-07 | 2008-03-05 | Koninklijke Philips Electronics N.V. | Erstellung von expressionsprofilen in vivo |
WO2007006039A2 (en) * | 2005-07-05 | 2007-01-11 | The Board Of Regents Of The University Of Texas System | Depth-resolved spectroscopy method and apparatus |
JP2007023058A (ja) * | 2005-07-12 | 2007-02-01 | Fujifilm Holdings Corp | 金属酸化物又は金属硫化物ナノ粒子蛍光体を用いる癌検出方法 |
US7787129B2 (en) | 2006-01-31 | 2010-08-31 | The Board Of Trustees Of The University Of Illinois | Method and apparatus for measurement of optical properties in tissue |
US7951776B2 (en) | 2006-09-01 | 2011-05-31 | American Type Culture Collection | Methods for treatment of type 1 diabetes |
EP2060916A4 (de) * | 2006-09-14 | 2010-09-22 | Konica Minolta Med & Graphic | Fluoreszenz-halbleitermikropartikelanordnung, fluoreszenzmarkierungsmittelanordnung für eine biologische substanz und biologisches bildgebungsverfahren sowie analyseverfahren für biologische substanzen mit verwendung der anordnungen |
US8026108B1 (en) * | 2006-10-19 | 2011-09-27 | The University Of Central Florida Research Foundation, Inc. | Detection of biotargets using bioreceptor functionalized nanoparticles |
US7654716B1 (en) | 2006-11-10 | 2010-02-02 | Doheny Eye Institute | Enhanced visualization illumination system |
WO2008140584A2 (en) | 2006-11-21 | 2008-11-20 | California Institute Of Technology | Second harmonic imaging nanoprobes and techniques for use thereof |
US8426152B2 (en) * | 2007-01-03 | 2013-04-23 | Lamdagen Corporation | Enzymatic assay for LSPR |
GB0701444D0 (en) * | 2007-01-25 | 2007-03-07 | Iti Scotland Ltd | Detecting analytes |
WO2008101019A2 (en) * | 2007-02-13 | 2008-08-21 | Board Of Regents, The University Of Texas System | Molecular specific photoacoustic imaging |
WO2008106590A2 (en) * | 2007-02-28 | 2008-09-04 | Doheny Eye Institute | Portable handheld illumination system |
EP2134642B1 (de) * | 2007-04-02 | 2016-02-24 | Emory University | SERS Nanopartikel-Marker und Verfahren zur spektroskopischen Erkennung von Tumoren |
WO2009009786A2 (en) | 2007-07-12 | 2009-01-15 | Board Of Regents, The University Of Texas System | Magneto-motive ultrasound detection of magnetic nanoparticles |
RU2488592C2 (ru) | 2007-08-08 | 2013-07-27 | Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем | Пептиды направленного действия на vegfr-1/nrp-1 |
ES2406105T3 (es) | 2007-08-15 | 2013-06-05 | Yeda Research And Development Co. Ltd. | Reguladores de la MMP-9 y usos de los mismos |
US8238942B2 (en) * | 2007-11-21 | 2012-08-07 | Trapeze Networks, Inc. | Wireless station location detection |
US7751057B2 (en) | 2008-01-18 | 2010-07-06 | The Board Of Trustees Of The University Of Illinois | Magnetomotive optical coherence tomography |
US8983580B2 (en) | 2008-01-18 | 2015-03-17 | The Board Of Trustees Of The University Of Illinois | Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors |
US8115934B2 (en) | 2008-01-18 | 2012-02-14 | The Board Of Trustees Of The University Of Illinois | Device and method for imaging the ear using optical coherence tomography |
US8488863B2 (en) * | 2008-11-06 | 2013-07-16 | Los Alamos National Security, Llc | Combinational pixel-by-pixel and object-level classifying, segmenting, and agglomerating in performing quantitative image analysis that distinguishes between healthy non-cancerous and cancerous cell nuclei and delineates nuclear, cytoplasm, and stromal material objects from stained biological tissue materials |
WO2010090844A2 (en) * | 2009-01-21 | 2010-08-12 | California Institute Of Technology | Multipurpose analysis using second harmonic generating nanoprobes |
US20100234762A1 (en) * | 2009-02-27 | 2010-09-16 | Gary Pond | Compositions and methods for detecting oral neoplasm |
US20120251443A1 (en) * | 2009-10-02 | 2012-10-04 | The Brigham And Women's Hospital, Inc. | Implantable contrast agents and methods |
WO2011143500A2 (en) | 2010-05-13 | 2011-11-17 | Doheny Eye Institute | Self contained illuminated infusion cannula systems and devices |
US9448173B2 (en) | 2011-03-08 | 2016-09-20 | The Board Of Trustees Of The University Of Illinois | Dye-conjugated dendrimers |
US9417240B2 (en) | 2011-05-27 | 2016-08-16 | Drexel University | Capped and conjugated quantum dots |
US9155497B1 (en) | 2011-06-02 | 2015-10-13 | Stc.Unm | Compact biosensor of matrix metalloproteinase with cadmium free quantum dots |
WO2013063588A1 (en) * | 2011-10-28 | 2013-05-02 | The Board Of Trustees Of The Leland Stanford Junior University | Ex vivo culture, proliferation and expansion of primary tissue organoids |
US9221919B2 (en) | 2011-11-21 | 2015-12-29 | California Institute Of Technology | Functionalization of and use of functionalized second harmonic generating nanoprobes |
US8984733B2 (en) | 2013-02-05 | 2015-03-24 | Artventive Medical Group, Inc. | Bodily lumen occlusion |
CN105122065B (zh) * | 2013-02-20 | 2018-05-25 | 康奈尔大学 | 多层荧光纳米颗粒及其制备和使用方法 |
US10149968B2 (en) * | 2013-06-14 | 2018-12-11 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9636116B2 (en) | 2013-06-14 | 2017-05-02 | Artventive Medical Group, Inc. | Implantable luminal devices |
US9092691B1 (en) * | 2014-07-18 | 2015-07-28 | Median Technologies | System for computing quantitative biomarkers of texture features in tomographic images |
CN106716116B (zh) | 2014-09-23 | 2021-04-27 | 蒂尔实验室研究有限公司 | 用于微流体泪液收集和感兴趣的分析物的横向流动分析的集成的系统和方法 |
WO2016049544A1 (en) | 2014-09-25 | 2016-03-31 | Northwestern University | Devices, methods, and systems relating to super resolution imaging |
US10588564B2 (en) * | 2014-09-30 | 2020-03-17 | Moein Health, LLC | Method and kit for diagnosing and treating neoplastic tissue |
US20160178519A1 (en) * | 2014-12-23 | 2016-06-23 | Boston Scientific Scimed, Inc. | Marker For Detection And Confirmation Of Peripheral Lung Nodules |
TWI608076B (zh) * | 2015-03-04 | 2017-12-11 | 納諾柯技術有限公司 | 以金屬硫醇聚合物穩定化的量子點 |
US10845312B2 (en) | 2015-07-22 | 2020-11-24 | The Board Of Regents Of The University Of Texas System | Label-free detection of sialic acid using surface-enhanced Raman scattering microscopy |
US10813644B2 (en) | 2016-04-01 | 2020-10-27 | Artventive Medical Group, Inc. | Occlusive implant and delivery system |
US11180735B2 (en) | 2016-10-28 | 2021-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods to preserve tumor-stromal interactions in culture and therapeutic predictive applications thereof |
US10634890B1 (en) | 2018-10-26 | 2020-04-28 | General Electric Company | Miniaturized microscope for phase contrast and multicolor fluorescence imaging |
US20220082500A1 (en) * | 2019-01-17 | 2022-03-17 | University Health Network | Tissue phantoms |
EP4069086A4 (de) * | 2019-12-05 | 2024-07-03 | Imaginab Inc | Bildgebungsverfahren unter verwendung mehrerer kontrastmittel |
IL314424A (en) * | 2022-01-19 | 2024-09-01 | Yellowbird Diagnostics Inc | Preparations containing metallic nanoparticles, methods for their preparation and uses |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8331514D0 (en) * | 1983-11-25 | 1984-01-04 | Janssen Pharmaceutica Nv | Visualization method |
US4752569A (en) * | 1984-06-21 | 1988-06-21 | The Regents Of The University Of California | Sialylated Lewisx epitope, antibodies and diagnosis |
GB8426467D0 (en) | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
WO1990006718A1 (en) | 1988-12-21 | 1990-06-28 | Massachusetts Institute Of Technology | A method for laser induced fluorescence of tissue |
WO1991000360A1 (en) | 1989-06-29 | 1991-01-10 | Medarex, Inc. | Bispecific reagents for aids therapy |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US5475096A (en) | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
EP0549692A4 (en) | 1990-09-21 | 1993-08-25 | Fred Hutchinson Cancer Research Center | Protein sequence-specific oligonucleotide sequences |
US5840867A (en) | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
JPH06508022A (ja) | 1991-02-21 | 1994-09-14 | ギリアド サイエンシズ,インコーポレイテッド | 生体分子に特異的なアプタマーおよび生産方法 |
WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
US5582981A (en) | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
US5217594A (en) * | 1992-01-15 | 1993-06-08 | Enzyme Technology Research Group, Inc. | Convenient determination of trace lead in whole blood and other fluids |
US5756291A (en) | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
US5421339A (en) | 1993-05-12 | 1995-06-06 | Board Of Regents, The University Of Texas System | Diagnosis of dysplasia using laser induced fluoroescence |
US6159445A (en) * | 1994-07-20 | 2000-12-12 | Nycomed Imaging As | Light imaging contrast agents |
US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
US5631146A (en) * | 1995-01-19 | 1997-05-20 | The General Hospital Corporation | DNA aptamers and catalysts that bind adenosine or adenosine-5'-phosphates and methods for isolation thereof |
US5991653A (en) * | 1995-03-14 | 1999-11-23 | Board Of Regents, The University Of Texas System | Near-infrared raman spectroscopy for in vitro and in vivo detection of cervical precancers |
US5697373A (en) | 1995-03-14 | 1997-12-16 | Board Of Regents, The University Of Texas System | Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies |
US6258576B1 (en) * | 1996-06-19 | 2001-07-10 | Board Of Regents, The University Of Texas System | Diagnostic method and apparatus for cervical squamous intraepithelial lesions in vitro and in vivo using fluorescence spectroscopy |
US5612540A (en) * | 1995-03-31 | 1997-03-18 | Board Of Regents, The University Of Texas Systems | Optical method for the detection of cervical neoplasias using fluorescence spectroscopy |
US5699795A (en) | 1995-03-31 | 1997-12-23 | Board Of Regents, The University Of Texas System | Optical probe for the detection of cervical neoplasia using fluorescence spectroscopy and apparatus incorporating same |
US6111095A (en) | 1995-06-07 | 2000-08-29 | Merck & Co., Inc. | Capped synthetic RNA, analogs, and aptamers |
DE19543750C2 (de) | 1995-11-24 | 1997-10-23 | Crinos Industria Farmaco | Cathepsin G inhibierende Aptamere |
WO1997031259A1 (en) * | 1996-02-22 | 1997-08-28 | Dexall Biomedical Labs, Inc. | Non-captive substrate liquid phase immunoassay |
US5750411A (en) * | 1996-06-03 | 1998-05-12 | Bayer Corporation | Sol particle decay protection immunoassay |
US5792613A (en) | 1996-06-12 | 1998-08-11 | The Curators Of The University Of Missouri | Method for obtaining RNA aptamers based on shape selection |
US5842995A (en) * | 1996-06-28 | 1998-12-01 | Board Of Regents, The Univerisity Of Texas System | Spectroscopic probe for in vivo measurement of raman signals |
US6135965A (en) * | 1996-12-02 | 2000-10-24 | Board Of Regents, The University Of Texas System | Spectroscopic detection of cervical pre-cancer using radial basis function networks |
US5939021A (en) * | 1997-01-23 | 1999-08-17 | Hansen; W. Peter | Homogeneous binding assay |
US5920399A (en) | 1997-03-18 | 1999-07-06 | Sandia Corporation | Multispectral imaging method and apparatus |
US5929985A (en) * | 1997-03-18 | 1999-07-27 | Sandia Corporation | Multispectral imaging probe |
US6275726B1 (en) * | 1997-05-15 | 2001-08-14 | Board Of Regents, The University Of Texas System | Methods of enhanced light transmission through turbid biological media |
EP1071473B1 (de) | 1997-10-20 | 2007-10-10 | Board Of Regents, The University Of Texas System | Essigsäure als signalverbesserendes kontrastmittel in der fluoreszenzspektroscopie |
US6087102A (en) * | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6699724B1 (en) * | 1998-03-11 | 2004-03-02 | Wm. Marsh Rice University | Metal nanoshells for biosensing applications |
DE59913716D1 (de) * | 1998-10-29 | 2006-09-07 | Dakocytomation Denmark As | Nachweis von säure-resistenten mikroorganismen im stuhl |
US6251616B1 (en) * | 1999-01-14 | 2001-06-26 | Biocrystal Ltd. | Methods and assay kits for detecting altered mononuclear cell phenotype related to a pro-tumor immune response |
US6465180B1 (en) * | 1999-03-17 | 2002-10-15 | The Regents Of The University Of California | Detection of premalignant melanocytes |
US20010055764A1 (en) * | 1999-05-07 | 2001-12-27 | Empedocles Stephen A. | Microarray methods utilizing semiconductor nanocrystals |
US6680377B1 (en) * | 1999-05-14 | 2004-01-20 | Brandeis University | Nucleic acid-based detection |
ATE459635T1 (de) * | 1999-10-26 | 2010-03-15 | Univ Utah Res Found | Fluoreszierende cobalamine und deren verwendung |
ATE419536T1 (de) * | 2002-03-05 | 2009-01-15 | Univ Texas | Biospezifische kontrastmittel |
-
2003
- 2003-03-05 AT AT03711417T patent/ATE419536T1/de not_active IP Right Cessation
- 2003-03-05 WO PCT/US2003/006730 patent/WO2003075765A1/en not_active Application Discontinuation
- 2003-03-05 DE DE60325564T patent/DE60325564D1/de not_active Expired - Lifetime
- 2003-03-05 AU AU2003213729A patent/AU2003213729A1/en not_active Abandoned
- 2003-03-05 EP EP03711417A patent/EP1487343B1/de not_active Expired - Lifetime
- 2003-03-05 CA CA002478083A patent/CA2478083A1/en not_active Abandoned
- 2003-03-05 US US10/382,136 patent/US20040023415A1/en not_active Abandoned
-
2007
- 2007-10-23 US US11/877,476 patent/US20090068108A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2478083A1 (en) | 2003-09-18 |
EP1487343A1 (de) | 2004-12-22 |
EP1487343B1 (de) | 2008-12-31 |
DE60325564D1 (de) | 2009-02-12 |
US20040023415A1 (en) | 2004-02-05 |
EP1487343A4 (de) | 2007-03-21 |
AU2003213729A1 (en) | 2003-09-22 |
WO2003075765A1 (en) | 2003-09-18 |
US20090068108A1 (en) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE419536T1 (de) | Biospezifische kontrastmittel | |
Fedele | Diagnostic aids in the screening of oral cancer | |
Lutz et al. | Spectral analysis of multiplex Raman probe signatures | |
Huang et al. | Gold nanoparticle based platforms for circulating cancer marker detection | |
WO2005020803A3 (en) | Raman imaging and sensing apparatus employing nanoantennas | |
Rahman et al. | Evaluation of a low-cost, portable imaging system for early detection of oral cancer | |
SG144722A1 (en) | Method and apparatus for detecting and imaging the presence of biological materials | |
Ulep et al. | Smartphone based on-chip fluorescence imaging and capillary flow velocity measurement for detecting ROR1+ cancer cells from buffy coat blood samples on dual-layer paper microfluidic chip | |
SG170061A1 (en) | Biomarkers useful for diagnosing prostate cancer, and methods thereof | |
EP2302079A3 (de) | Verfahren zur Diagnose von systemischem Lupus erythematosus | |
CN113167791A (zh) | 作为通用增强剂的超亮荧光纳米构建体 | |
Poh et al. | Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era | |
EP1917528A4 (de) | Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors | |
TW200801202A (en) | Alpha-enolase specific antibody and method of use | |
Awan | Oral cancer: Early detection is crucial | |
WO2006014576A3 (en) | Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals | |
Baeten et al. | Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectins | |
Tukimin et al. | Polarized light-based cancer cell detection techniques: a review | |
Mahfoud et al. | Detection of ErbB2: nanotechnological solutions for clinical diagnostics | |
Chakraborty et al. | Nano‐diagnostics as an emerging platform for oral cancer detection: Current and emerging trends | |
KR20110039170A (ko) | 나노 스페이서를 이용한 광학 센서 및 광학 센서를 이용한 검출 방법 | |
Suthar et al. | Recent developments in biosensing methods for extracellular vesicle protein characterization | |
Sun et al. | Noise reduction method for quantifying nanoparticle light scattering in low magnification dark-field microscope far-field images | |
WO2006007064A3 (en) | System and method for spectroscopy and imaging | |
WO2004096971A3 (de) | Verfahren zur schnellen bestimmung von qualitäten/qualitätsänderungen beliebiger systeme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |